Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA
|
BSE: 524715
|
ISIN: INE044A01036
|
Industry: Pharmaceuticals
Acquisition
|
Mid-range Performer
1654.9000
-62.20
(
-3.62
%)
NSE
Apr 10, 2026
15:31 PM
Volume:
8.1M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Sun Pharmaceutical Industries Ltd.
08 Dec 2022
Acquisition
1654.90
-3.62%
Sun Pharma's Halol plant gets USFDA import alert
Business Line
Sun Pharma is second Indian drugmaker to get import alert in less than two months
Sun Pharmaceutical I.. has an
average target
of 1940.86 from 7 brokers.
Sun Pharma's Halol facility listed under USFDA import alert
Moneycontrol |
08 Dec 2022
4 more
Sun Pharma plant in Gujarat listed under US FDA import alert, says company
Business Standard |
08 Dec 2022
Sun Pharma says plant listed under U.S. FDA import alert
Business Line |
08 Dec 2022
Sun Pharma slips nearly 4% as USFDA issues import alert on Halol facility
Business Standard |
08 Dec 2022
USFDA lists Sun Pharma's Halol facility under 'import alert'
Moneycontrol |
08 Dec 2022
More from Sun Pharmaceutical Industries Ltd.
Recommended
Dividend yields vary across sectors, but Indian IT comes out on top
The Baseline |
10 Apr 2026, 06:26PM
Five Interesting Stocks Today - April 10, 2026
The Baseline |
10 Apr 2026, 05:54PM
Change is hard, and some Indian pharma companies are embracing it better than others
|
09 Aug 2022